2022. Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro. Baghdad Science Journal. 19, 2 (Apr. 2022), 0255. DOI:https://doi.org/10.21123/bsj.2022.19.2.0255.